Antony Clark

Antony Clark serves as a Senior Research Fellow at the Centre for Ophthalmology and Visual Science within the UWA Medical School at The University of Western Australia, maintaining clinical appointments as an Ophthalmologist at Perth Children’s Hospital, Lions Eye Institute, and Sir Charles Gairdner Hospital since 2016-2017.

His academic credentials include a PhD in Public Health from Curtin University (2014) focused on "Blinding Eye Diseases in Western Australia: Perspectives on data integration" and an MBBS (Hons) in Medicine and Surgery from UWA Medical School (2004).

Dr. Clark's research centers on ophthalmic epidemiology with dual emphases: myopia control through low-concentration atropine therapies (including rebound effects and choroidal changes) and population-level analysis of eye injuries. His work integrates optical coherence tomography, pediatric ophthalmology, and clinical trial methodology, frequently addressing Australian multi-racial cohorts and pandemic-related impacts on eye health.

Recent publications demonstrate a clear trend toward high-impact clinical translation, with 2024 studies on atropine discontinuation effects and myopia progression receiving significant media attention and social media engagement across multiple platforms.

His scientific recognition includes:

• Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO)

As principal or co-investigator on four major grants, Dr. Clark has led the WA ATOM myopia treatment studies (2016-2018), secured NHMRC funding for OCT imaging systems (2020), and developed zebrafish models for myopia research (2022), demonstrating strong collaborative networks across clinical and research institutions.

He operates within the Lions Eye Institute-affiliated research ecosystem at UWA, coordinating multidisciplinary teams that bridge laboratory science, clinical ophthalmology, and public health data analysis to address vision impairment challenges in Western Australia.